DK1294739T3 - 16,17-carbocykliske kondenserede steroidforbindelser med selektiv östrogenaktivitet - Google Patents

16,17-carbocykliske kondenserede steroidforbindelser med selektiv östrogenaktivitet

Info

Publication number
DK1294739T3
DK1294739T3 DK01931676T DK01931676T DK1294739T3 DK 1294739 T3 DK1294739 T3 DK 1294739T3 DK 01931676 T DK01931676 T DK 01931676T DK 01931676 T DK01931676 T DK 01931676T DK 1294739 T3 DK1294739 T3 DK 1294739T3
Authority
DK
Denmark
Prior art keywords
selective estrogen
steroid compounds
estrogen activity
carbocyclic condensed
carbocyclic
Prior art date
Application number
DK01931676T
Other languages
Danish (da)
English (en)
Inventor
Hubert Jan Jozef Loozen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1294739T3 publication Critical patent/DK1294739T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01931676T 2000-06-06 2001-05-01 16,17-carbocykliske kondenserede steroidforbindelser med selektiv östrogenaktivitet DK1294739T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201986 2000-06-06
PCT/EP2001/004868 WO2002000682A1 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Publications (1)

Publication Number Publication Date
DK1294739T3 true DK1294739T3 (da) 2005-08-01

Family

ID=8171601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01931676T DK1294739T3 (da) 2000-06-06 2001-05-01 16,17-carbocykliske kondenserede steroidforbindelser med selektiv östrogenaktivitet

Country Status (27)

Country Link
US (3) US7868193B2 (no)
EP (1) EP1294739B1 (no)
JP (1) JP5095902B2 (no)
KR (1) KR100769865B1 (no)
CN (1) CN1235908C (no)
AR (1) AR028080A1 (no)
AT (1) ATE293124T1 (no)
AU (2) AU5838601A (no)
BR (1) BR0111445A (no)
CA (1) CA2410220C (no)
CZ (1) CZ20024014A3 (no)
DE (1) DE60110069T2 (no)
DK (1) DK1294739T3 (no)
ES (1) ES2240454T3 (no)
HK (1) HK1052012A1 (no)
HU (1) HUP0301190A3 (no)
IL (1) IL152957A0 (no)
MX (1) MXPA02012117A (no)
NO (1) NO324247B1 (no)
PE (1) PE20020214A1 (no)
PL (1) PL203732B1 (no)
PT (1) PT1294739E (no)
RU (1) RU2255090C2 (no)
SK (1) SK286852B6 (no)
TW (1) TWI225068B (no)
WO (1) WO2002000682A1 (no)
ZA (1) ZA200209452B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194821A (en) * 1963-12-30 1965-07-13 Abbott Lab 17alpha-substituted 17beta-hydroxyestrenes
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
IL123195A (en) * 1997-02-21 2002-11-10 Akzo Nobel Nv Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
HUP0301190A3 (en) 2010-03-29
WO2002000682A1 (en) 2002-01-03
CA2410220A1 (en) 2002-01-03
US20110224183A1 (en) 2011-09-15
JP5095902B2 (ja) 2012-12-12
NO324247B1 (no) 2007-09-17
CN1433426A (zh) 2003-07-30
PT1294739E (pt) 2005-06-30
US20100249083A1 (en) 2010-09-30
AR028080A1 (es) 2003-04-23
US20040102426A1 (en) 2004-05-27
TWI225068B (en) 2004-12-11
SK17072002A3 (sk) 2003-06-03
PL203732B1 (pl) 2009-11-30
CN1235908C (zh) 2006-01-11
ZA200209452B (en) 2004-02-20
DE60110069D1 (de) 2005-05-19
PE20020214A1 (es) 2002-03-13
AU5838601A (en) 2002-01-08
EP1294739A1 (en) 2003-03-26
KR20030028752A (ko) 2003-04-10
IL152957A0 (en) 2003-06-24
US7868193B2 (en) 2011-01-11
PL359238A1 (en) 2004-08-23
BR0111445A (pt) 2003-06-03
CZ20024014A3 (cs) 2003-04-16
RU2255090C2 (ru) 2005-06-27
ATE293124T1 (de) 2005-04-15
DE60110069T2 (de) 2005-09-22
KR100769865B1 (ko) 2007-10-25
CA2410220C (en) 2009-04-28
AU2001258386B2 (en) 2005-08-18
SK286852B6 (sk) 2009-06-05
HUP0301190A2 (hu) 2003-08-28
MXPA02012117A (es) 2003-06-06
HK1052012A1 (en) 2003-08-29
EP1294739B1 (en) 2005-04-13
ES2240454T3 (es) 2005-10-16
JP2004501931A (ja) 2004-01-22
NO20025793L (no) 2002-12-02
NO20025793D0 (no) 2002-12-02

Similar Documents

Publication Publication Date Title
DE60126597D1 (de) 3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon
DE60111734D1 (de) [1,4']-bipiperidin verbindungen
NO20015314L (no) Steroidderivater
HK1050254A1 (en) Isolated instructions for isolated execution.
PT1177185E (pt) Derivados de 4, 5, 6, 7-tetra-hidroindazole como agentes antitumorais
DE50000124D1 (de) Stanzniet
NO20031737L (no) Östrogenreseptormodulatorer
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
NO20013860L (no) 16-hydroksyöstratriener som selektive östrogener
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
ATE317396T1 (de) 14,15-beta-methylen substituierte androgene
DK2067772T3 (da) Dibenz[b,f]azapin-mellemprodukter
DK1294739T3 (da) 16,17-carbocykliske kondenserede steroidforbindelser med selektiv östrogenaktivitet
MXPA03004658A (es) Compuestos activos en el receptor glucocorticoide ii.
ES1043131Y (es) Tejido perfeccionado.
DK0973790T3 (da) Estra-5(10),7-diener med østrogen aktivitet
DE60112022D1 (de) Lenksäulenverkleidung
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
ES1041748Y (es) Pantalon perfeccionado.
FR2789393B1 (fr) Lactol steroidique
IT246053Y1 (it) Calzare termico perfezionato, particolarmente per uso sportivo
ES1042333Y (es) Prenda perfeccionada.
DK1274687T3 (da) 1,2,3,4-tetrahydroisoquinolinderivater
ES1041554Y (es) Pantalon perfeccionado.
DE19980008D2 (de) Gestricktes, Körperbetonendes Bekleidungsteil